US Equity
CTMX
— CYTOMX THERAPEUTICS, INC.CytomX Therapeutics, Inc. is a biotechnology company that develops conditionally activated antibody therapeutics using its Probody technology platform for cancer treatment.
💰 Market cap: $707.53M📍 151 Oyster Point Blvd., Suite 400, SOUTH SAN FRANCISCO, CA, 94080 US🏷️ Biotechnology & Medical Research💵 Previous close: $3.24🔢 6,956 credits left
Add Column
All
Trend
| Date ▾ | Close ▾ |
|---|---|
| 2026-07-24 | $3.24 |
| 2026-07-23 | $3.33 |
| 2026-07-22 | $3.33 |
| 2026-07-21 | $3.42 |
| 2026-07-20 | $3.52 |
| 2026-07-17 | $3.62 |
| 2026-07-16 | $3.67 |
| 2026-07-15 | $3.68 |
| 2026-07-14 | $3.66 |
| 2026-07-13 | $3.70 |
| 2026-07-10 | $3.76 |
| 2026-07-09 | $3.96 |
| 2026-07-08 | $3.83 |
| 2026-07-07 | $3.84 |
| 2026-07-06 | $3.81 |
| 2026-07-02 | $3.82 |
| 2026-07-01 | $3.60 |
| 2026-06-30 | $3.75 |
| 2026-06-29 | $3.74 |
| 2026-06-26 | $3.40 |
| 2026-06-25 | $3.27 |
| 2026-06-24 | $3.32 |
| 2026-06-23 | $3.15 |
| 2026-06-22 | $3.04 |
| 2026-06-18 | $2.95 |
| 2026-06-17 | $2.96 |
| 2026-06-16 | $2.93 |
| 2026-06-15 | $3.04 |
| 2026-06-12 | $3.01 |
| 2026-06-11 | $2.98 |
| 2026-06-10 | $2.91 |
| 2026-06-09 | $2.98 |
| 2026-06-08 | $2.94 |
| 2026-06-05 | $3.00 |
| 2026-06-04 | $3.18 |
| 2026-06-03 | $3.22 |
| 2026-06-02 | $3.16 |
| 2026-06-01 | $3.45 |
| 2026-05-29 | $3.60 |
| 2026-05-28 | $3.71 |
| 2026-05-27 | $3.81 |
| 2026-05-26 | $3.69 |
| 2026-05-22 | $3.76 |
| 2026-05-21 | $3.76 |
| 2026-05-20 | $3.72 |
| 2026-05-19 | $3.64 |
| 2026-05-18 | $3.50 |
| 2026-05-15 | $3.61 |
| 2026-05-14 | $3.78 |
| 2026-05-13 | $3.79 |
| 2026-05-12 | $3.88 |
| 2026-05-11 | $3.86 |
| 2026-05-08 | $3.98 |
| 2026-05-07 | $4.00 |
| 2026-05-06 | $4.13 |
| 2026-05-05 | $4.08 |
| 2026-05-04 | $4.18 |
| 2026-05-01 | $4.18 |
| 2026-04-30 | $4.22 |
| 2026-04-29 | $4.05 |
| 2026-04-28 | $4.12 |